Search Results - Brückl, Wolfgang M.

Efficacy of docetaxel plus ramucirumab as palliative third-line therapy following second-line immune-checkpoint-inhibitor treatment in patients with non-small-cell lung cancer stag... by Brückl, Wolfgang M. (Author) , Reck, Martin (Author) , Rittmeyer, Achim (Author) , Kollmeier, Jens (Author) , Wesseler, Claas (Author) , Wiest, Gunther H. (Author) , Christopoulos, Petros (Author) , Tufman, Amanda (Author) , Hoffknecht, Petra (Author) , Ulm, Bernhard (Author) , Reich, Fabian (Author) , Ficker, Joachim H. (Author) , Laack, Eckart (Author) ,

• Verlag, lizenzpflichtig, Volltext
• Verlag, lizenzpflichtig, Volltext

Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): real-world data on survival and safety from the German expanded-a... by Faehling, Martin (Author) , Schumann, Christian (Author) , Christopoulos, Petros (Author) , Hoffknecht, Petra (Author) , Alt, Jürgen (Author) , Horn, Marlitt (Author) , Eisenmann, Stephan (Author) , Schlenska-Lange, Anke (Author) , Schütt, Philipp (Author) , Steger, Felix (Author) , Brückl, Wolfgang M. (Author) , Christoph, Daniel C. (Author) ,

• Resolving-System, lizenzpflichtig